Catherine Lozupone
Concepts (399)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Microbiome | 31 | 2026 | 766 | 5.580 |
Why?
| | Microbiota | 24 | 2026 | 729 | 4.780 |
Why?
| | Bacteria | 40 | 2025 | 765 | 4.610 |
Why?
| | Phylogeny | 28 | 2020 | 917 | 2.350 |
Why?
| | Software | 11 | 2026 | 678 | 2.170 |
Why?
| | HIV Infections | 21 | 2026 | 3186 | 2.140 |
Why?
| | Computational Biology | 9 | 2026 | 669 | 2.130 |
Why?
| | RNA, Ribosomal, 16S | 30 | 2025 | 507 | 1.600 |
Why?
| | Metagenome | 13 | 2015 | 126 | 1.530 |
Why?
| | Prevotella | 2 | 2025 | 26 | 1.490 |
Why?
| | Feces | 18 | 2025 | 494 | 1.480 |
Why?
| | Biodiversity | 12 | 2018 | 311 | 1.320 |
Why?
| | Gastrointestinal Tract | 13 | 2019 | 204 | 1.300 |
Why?
| | Intestines | 8 | 2018 | 354 | 1.160 |
Why?
| | Interleukin-10 | 3 | 2022 | 309 | 1.160 |
Why?
| | Symbiosis | 6 | 2020 | 72 | 1.110 |
Why?
| | Dysbiosis | 5 | 2021 | 187 | 1.110 |
Why?
| | Anti-Retroviral Agents | 5 | 2024 | 251 | 0.910 |
Why?
| | Polysaccharides, Bacterial | 4 | 2025 | 69 | 0.890 |
Why?
| | Metabolome | 2 | 2019 | 387 | 0.870 |
Why?
| | Diet | 5 | 2026 | 1277 | 0.790 |
Why?
| | Homosexuality, Male | 6 | 2026 | 231 | 0.750 |
Why?
| | Leukocytes, Mononuclear | 3 | 2022 | 573 | 0.720 |
Why?
| | Sexual and Gender Minorities | 4 | 2022 | 259 | 0.700 |
Why?
| | Bacterial Toxins | 1 | 2022 | 108 | 0.690 |
Why?
| | Immune System | 2 | 2019 | 177 | 0.660 |
Why?
| | Ecosystem | 10 | 2017 | 478 | 0.660 |
Why?
| | Inflammatory Bowel Diseases | 2 | 2025 | 364 | 0.660 |
Why?
| | Metabolic Networks and Pathways | 2 | 2019 | 174 | 0.650 |
Why?
| | Blood Group Antigens | 1 | 2020 | 15 | 0.640 |
Why?
| | Disease | 2 | 2019 | 96 | 0.630 |
Why?
| | Health | 2 | 2017 | 82 | 0.590 |
Why?
| | Audiovisual Aids | 1 | 2019 | 11 | 0.580 |
Why?
| | DNA, Bacterial | 7 | 2019 | 320 | 0.570 |
Why?
| | Bacterial Infections | 2 | 2020 | 246 | 0.570 |
Why?
| | Immunotherapy | 2 | 2025 | 665 | 0.560 |
Why?
| | Humans | 79 | 2026 | 145140 | 0.550 |
Why?
| | Parkinson Disease | 1 | 2025 | 599 | 0.550 |
Why?
| | Dolphins | 1 | 2017 | 2 | 0.540 |
Why?
| | Soil Microbiology | 6 | 2011 | 115 | 0.540 |
Why?
| | Anti-Inflammatory Agents | 2 | 2022 | 477 | 0.520 |
Why?
| | Genetic Techniques | 2 | 2008 | 66 | 0.500 |
Why?
| | Genetic Variation | 9 | 2011 | 967 | 0.490 |
Why?
| | Metagenomics | 5 | 2013 | 149 | 0.490 |
Why?
| | Obesity | 6 | 2026 | 3097 | 0.470 |
Why?
| | Sequence Analysis, DNA | 11 | 2017 | 776 | 0.450 |
Why?
| | Bacterial Physiological Phenomena | 5 | 2020 | 47 | 0.440 |
Why?
| | Zimbabwe | 2 | 2026 | 76 | 0.440 |
Why?
| | Archaea | 3 | 2011 | 61 | 0.420 |
Why?
| | Immune Tolerance | 1 | 2016 | 385 | 0.410 |
Why?
| | Animals | 37 | 2025 | 37952 | 0.410 |
Why?
| | Biota | 1 | 2013 | 29 | 0.400 |
Why?
| | Tropheryma | 1 | 2013 | 6 | 0.390 |
Why?
| | Whipple Disease | 1 | 2013 | 7 | 0.390 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2016 | 407 | 0.390 |
Why?
| | Ecology | 3 | 2011 | 105 | 0.380 |
Why?
| | Inflammation | 6 | 2026 | 2876 | 0.380 |
Why?
| | Microbiological Techniques | 2 | 2010 | 30 | 0.350 |
Why?
| | Cluster Analysis | 8 | 2010 | 500 | 0.350 |
Why?
| | Liver Transplantation | 1 | 2019 | 826 | 0.350 |
Why?
| | Molecular Sequence Data | 15 | 2013 | 2881 | 0.330 |
Why?
| | Host-Pathogen Interactions | 5 | 2024 | 361 | 0.330 |
Why?
| | Genes, Bacterial | 4 | 2011 | 152 | 0.330 |
Why?
| | Body Mass Index | 5 | 2026 | 2437 | 0.320 |
Why?
| | Genes, Archaeal | 1 | 2008 | 5 | 0.290 |
Why?
| | Glycosyltransferases | 1 | 2008 | 16 | 0.280 |
Why?
| | Data Interpretation, Statistical | 1 | 2010 | 368 | 0.280 |
Why?
| | Glycoside Hydrolases | 1 | 2008 | 38 | 0.280 |
Why?
| | Longitudinal Studies | 3 | 2026 | 2949 | 0.270 |
Why?
| | Weight Loss | 2 | 2026 | 845 | 0.270 |
Why?
| | Antigens, CD | 3 | 2025 | 558 | 0.260 |
Why?
| | Isoleucine | 2 | 2005 | 15 | 0.260 |
Why?
| | Hot Springs | 1 | 2007 | 8 | 0.250 |
Why?
| | Digestive System | 1 | 2007 | 29 | 0.250 |
Why?
| | Male | 27 | 2026 | 72664 | 0.250 |
Why?
| | Geologic Sediments | 1 | 2007 | 46 | 0.250 |
Why?
| | Clostridium Infections | 2 | 2025 | 74 | 0.250 |
Why?
| | Germ-Free Life | 4 | 2025 | 33 | 0.240 |
Why?
| | Evolution, Molecular | 5 | 2012 | 490 | 0.240 |
Why?
| | Genome, Bacterial | 5 | 2021 | 123 | 0.230 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2019 | 265 | 0.230 |
Why?
| | Mice | 15 | 2025 | 18303 | 0.220 |
Why?
| | Adult | 18 | 2026 | 40665 | 0.220 |
Why?
| | RNA | 3 | 2012 | 910 | 0.220 |
Why?
| | Phytochemicals | 1 | 2025 | 13 | 0.220 |
Why?
| | Tea | 1 | 2025 | 17 | 0.220 |
Why?
| | Ciliophora | 2 | 2003 | 15 | 0.220 |
Why?
| | Female | 28 | 2026 | 78636 | 0.210 |
Why?
| | Cohort Studies | 9 | 2021 | 5988 | 0.210 |
Why?
| | Workflow | 1 | 2026 | 183 | 0.210 |
Why?
| | Metabolomics | 4 | 2026 | 730 | 0.200 |
Why?
| | Receptors, CCR5 | 2 | 2021 | 60 | 0.200 |
Why?
| | Anti-Bacterial Agents | 4 | 2025 | 1922 | 0.200 |
Why?
| | Homeostasis | 2 | 2018 | 639 | 0.200 |
Why?
| | Neoplasms | 1 | 2019 | 2900 | 0.190 |
Why?
| | Lung | 2 | 2013 | 4101 | 0.190 |
Why?
| | Colonic Neoplasms | 1 | 2025 | 257 | 0.190 |
Why?
| | Overweight | 2 | 2026 | 609 | 0.190 |
Why?
| | HIV | 2 | 2019 | 251 | 0.190 |
Why?
| | Urban Population | 1 | 2026 | 492 | 0.190 |
Why?
| | Middle Aged | 12 | 2026 | 36126 | 0.190 |
Why?
| | Bifidobacterium | 3 | 2017 | 21 | 0.190 |
Why?
| | Internet | 2 | 2011 | 689 | 0.190 |
Why?
| | Bacteroides fragilis | 1 | 2022 | 14 | 0.180 |
Why?
| | High-Throughput Nucleotide Sequencing | 4 | 2018 | 530 | 0.180 |
Why?
| | Bacteroides | 3 | 2019 | 20 | 0.180 |
Why?
| | Killer Cells, Natural | 1 | 2025 | 478 | 0.180 |
Why?
| | DNA, Ribosomal | 3 | 2013 | 84 | 0.180 |
Why?
| | Base Sequence | 9 | 2017 | 2168 | 0.170 |
Why?
| | Environment | 3 | 2012 | 293 | 0.170 |
Why?
| | Intestinal Mucosa | 2 | 2021 | 674 | 0.170 |
Why?
| | Biological Evolution | 4 | 2009 | 466 | 0.170 |
Why?
| | Peptide Termination Factors | 1 | 2001 | 5 | 0.170 |
Why?
| | Antiretroviral Therapy, Highly Active | 3 | 2020 | 279 | 0.170 |
Why?
| | Genetic Code | 1 | 2001 | 24 | 0.170 |
Why?
| | Rural Population | 1 | 2026 | 657 | 0.170 |
Why?
| | Infant | 8 | 2021 | 10060 | 0.160 |
Why?
| | RNA, Bacterial | 4 | 2010 | 182 | 0.160 |
Why?
| | Sexual Behavior | 3 | 2020 | 494 | 0.160 |
Why?
| | Intestinal Diseases, Parasitic | 1 | 2020 | 12 | 0.160 |
Why?
| | T-Lymphocytopenia, Idiopathic CD4-Positive | 1 | 2020 | 6 | 0.160 |
Why?
| | Dietary Fats | 1 | 2022 | 308 | 0.150 |
Why?
| | Machine Learning | 1 | 2026 | 586 | 0.150 |
Why?
| | Benzopyrans | 1 | 2019 | 30 | 0.150 |
Why?
| | Western World | 1 | 2019 | 7 | 0.150 |
Why?
| | Weight Reduction Programs | 1 | 2021 | 138 | 0.150 |
Why?
| | Hypersensitivity | 1 | 2022 | 254 | 0.150 |
Why?
| | Asthma | 3 | 2022 | 1795 | 0.150 |
Why?
| | Thiophenes | 1 | 2019 | 117 | 0.150 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 2020 | 130 | 0.140 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2021 | 1138 | 0.140 |
Why?
| | Liver Regeneration | 1 | 2019 | 46 | 0.140 |
Why?
| | Datasets as Topic | 1 | 2019 | 118 | 0.140 |
Why?
| | Sequence Analysis | 2 | 2009 | 34 | 0.140 |
Why?
| | Programmed Cell Death 1 Receptor | 2 | 2019 | 264 | 0.140 |
Why?
| | Behavior Therapy | 1 | 2021 | 294 | 0.130 |
Why?
| | Genes, rRNA | 4 | 2017 | 38 | 0.130 |
Why?
| | Transplantation, Homologous | 1 | 2019 | 417 | 0.130 |
Why?
| | Streptococcus | 1 | 2017 | 29 | 0.130 |
Why?
| | Mouth | 1 | 2017 | 86 | 0.130 |
Why?
| | Microbial Consortia | 1 | 2017 | 11 | 0.130 |
Why?
| | Weight Gain | 2 | 2018 | 561 | 0.130 |
Why?
| | Bacterial Load | 1 | 2017 | 67 | 0.120 |
Why?
| | Environmental Microbiology | 2 | 2007 | 47 | 0.120 |
Why?
| | Gene Transfer, Horizontal | 4 | 2010 | 34 | 0.120 |
Why?
| | Cholestasis | 1 | 2019 | 213 | 0.120 |
Why?
| | Cross-Sectional Studies | 2 | 2026 | 5886 | 0.120 |
Why?
| | Leukemia | 1 | 2018 | 246 | 0.120 |
Why?
| | Algorithms | 2 | 2022 | 1845 | 0.120 |
Why?
| | Life Style | 1 | 2018 | 483 | 0.120 |
Why?
| | Nucleic Acid Conformation | 2 | 2012 | 723 | 0.120 |
Why?
| | Microbial Interactions | 1 | 2016 | 18 | 0.120 |
Why?
| | Geography | 4 | 2012 | 185 | 0.120 |
Why?
| | Disease Models, Animal | 5 | 2024 | 4552 | 0.120 |
Why?
| | Th17 Cells | 1 | 2016 | 100 | 0.110 |
Why?
| | Microbiology | 1 | 2015 | 24 | 0.110 |
Why?
| | Single-Cell Analysis | 1 | 2019 | 361 | 0.110 |
Why?
| | Gastrointestinal Diseases | 1 | 2017 | 221 | 0.110 |
Why?
| | Pregnancy | 4 | 2017 | 7182 | 0.110 |
Why?
| | Graft vs Host Disease | 1 | 2017 | 278 | 0.110 |
Why?
| | Benchmarking | 1 | 2016 | 188 | 0.110 |
Why?
| | Probability | 1 | 2015 | 307 | 0.110 |
Why?
| | Pediatric Obesity | 2 | 2019 | 637 | 0.100 |
Why?
| | Molecular Targeted Therapy | 1 | 2017 | 438 | 0.100 |
Why?
| | Sequence Alignment | 2 | 2012 | 362 | 0.100 |
Why?
| | Genomics | 2 | 2011 | 819 | 0.100 |
Why?
| | Colitis | 1 | 2016 | 280 | 0.100 |
Why?
| | Premature Birth | 1 | 2017 | 387 | 0.100 |
Why?
| | Infant, Newborn | 3 | 2020 | 6435 | 0.100 |
Why?
| | Glucose | 1 | 2018 | 1048 | 0.100 |
Why?
| | Pets | 1 | 2013 | 24 | 0.100 |
Why?
| | Insulin Resistance | 2 | 2018 | 1244 | 0.100 |
Why?
| | Tongue | 1 | 2013 | 76 | 0.090 |
Why?
| | Pregnancy Trimester, First | 1 | 2013 | 138 | 0.090 |
Why?
| | Environmental Exposure | 1 | 2017 | 577 | 0.090 |
Why?
| | Clostridium | 1 | 2012 | 19 | 0.090 |
Why?
| | Liver Neoplasms | 1 | 2019 | 775 | 0.090 |
Why?
| | Databases, Nucleic Acid | 1 | 2012 | 38 | 0.090 |
Why?
| | Anti-HIV Agents | 2 | 2017 | 908 | 0.090 |
Why?
| | Autism Spectrum Disorder | 1 | 2017 | 420 | 0.090 |
Why?
| | Housing | 1 | 2013 | 142 | 0.090 |
Why?
| | nef Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 19 | 0.090 |
Why?
| | Cultured Milk Products | 1 | 2011 | 1 | 0.090 |
Why?
| | Colon | 2 | 2020 | 308 | 0.090 |
Why?
| | Fishes | 1 | 2012 | 109 | 0.090 |
Why?
| | Antibodies, Monoclonal | 1 | 2019 | 1505 | 0.090 |
Why?
| | Macaca mulatta | 2 | 2012 | 186 | 0.090 |
Why?
| | Simian Immunodeficiency Virus | 1 | 2012 | 93 | 0.080 |
Why?
| | Methanobrevibacter | 1 | 2011 | 1 | 0.080 |
Why?
| | Genome, Archaeal | 1 | 2011 | 12 | 0.080 |
Why?
| | Mucin-5B | 1 | 2013 | 234 | 0.080 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 1 | 2012 | 92 | 0.080 |
Why?
| | Respiratory Mucosa | 1 | 2013 | 322 | 0.080 |
Why?
| | Cameroon | 2 | 2021 | 8 | 0.080 |
Why?
| | Phenotype | 1 | 2019 | 3138 | 0.080 |
Why?
| | Adhesins, Bacterial | 1 | 2011 | 44 | 0.080 |
Why?
| | RNA, Ribosomal | 2 | 2010 | 168 | 0.080 |
Why?
| | Behavioral Symptoms | 1 | 2011 | 41 | 0.080 |
Why?
| | DNA Barcoding, Taxonomic | 1 | 2010 | 16 | 0.080 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2012 | 237 | 0.080 |
Why?
| | Mice, Inbred C57BL | 5 | 2025 | 5972 | 0.080 |
Why?
| | HIV-1 | 2 | 2018 | 906 | 0.080 |
Why?
| | Child, Preschool | 7 | 2021 | 11835 | 0.080 |
Why?
| | Adolescent | 9 | 2021 | 22479 | 0.080 |
Why?
| | Risk Factors | 3 | 2020 | 10857 | 0.080 |
Why?
| | Twins | 1 | 2011 | 151 | 0.080 |
Why?
| | Residence Characteristics | 1 | 2013 | 373 | 0.080 |
Why?
| | Comorbidity | 3 | 2022 | 1657 | 0.080 |
Why?
| | Child | 9 | 2022 | 22670 | 0.080 |
Why?
| | Crohn Disease | 1 | 2013 | 258 | 0.080 |
Why?
| | Young Adult | 7 | 2021 | 14176 | 0.070 |
Why?
| | Liver | 1 | 2018 | 1893 | 0.070 |
Why?
| | Fungi | 1 | 2010 | 121 | 0.070 |
Why?
| | Genome | 2 | 2010 | 304 | 0.070 |
Why?
| | Soil | 1 | 2010 | 145 | 0.070 |
Why?
| | Surveys and Questionnaires | 2 | 2018 | 6055 | 0.070 |
Why?
| | Virus Replication | 2 | 2012 | 519 | 0.070 |
Why?
| | CD4 Lymphocyte Count | 2 | 2021 | 280 | 0.070 |
Why?
| | Carbohydrates | 1 | 2008 | 66 | 0.070 |
Why?
| | Norway | 2 | 2018 | 41 | 0.070 |
Why?
| | Viral Load | 3 | 2018 | 525 | 0.070 |
Why?
| | Family | 1 | 2013 | 682 | 0.070 |
Why?
| | Vertebrates | 1 | 2008 | 63 | 0.070 |
Why?
| | Lentivirus Infections | 1 | 2008 | 9 | 0.070 |
Why?
| | Skin | 1 | 2013 | 753 | 0.070 |
Why?
| | Enterocolitis | 1 | 2008 | 18 | 0.070 |
Why?
| | Monkey Diseases | 1 | 2008 | 25 | 0.070 |
Why?
| | Multigene Family | 1 | 2008 | 209 | 0.070 |
Why?
| | Sequence Analysis, RNA | 1 | 2010 | 442 | 0.070 |
Why?
| | Cytokines | 3 | 2021 | 2048 | 0.060 |
Why?
| | Antineoplastic Agents | 1 | 2019 | 2207 | 0.060 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2008 | 196 | 0.060 |
Why?
| | Adaptation, Biological | 1 | 2007 | 48 | 0.060 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2007 | 187 | 0.060 |
Why?
| | Twins, Monozygotic | 3 | 2012 | 133 | 0.060 |
Why?
| | Mammals | 1 | 2008 | 284 | 0.060 |
Why?
| | Demography | 1 | 2007 | 282 | 0.060 |
Why?
| | Models, Biological | 2 | 2013 | 1763 | 0.060 |
Why?
| | Biomarkers | 3 | 2017 | 4282 | 0.060 |
Why?
| | Postoperative Complications | 1 | 2019 | 2961 | 0.060 |
Why?
| | Polymorphism, Genetic | 2 | 2010 | 614 | 0.060 |
Why?
| | Oligoribonucleotides | 1 | 2005 | 53 | 0.060 |
Why?
| | Viruses | 1 | 2007 | 164 | 0.060 |
Why?
| | Adaptation, Physiological | 4 | 2011 | 560 | 0.060 |
Why?
| | DNA Primers | 2 | 2007 | 505 | 0.050 |
Why?
| | Neurotransmitter Agents | 2 | 2017 | 83 | 0.050 |
Why?
| | Species Specificity | 3 | 2011 | 545 | 0.050 |
Why?
| | Principal Component Analysis | 2 | 2018 | 191 | 0.050 |
Why?
| | Diarrhea | 1 | 2025 | 193 | 0.050 |
Why?
| | DNA Polymerase I | 1 | 2003 | 31 | 0.050 |
Why?
| | Age Factors | 3 | 2018 | 3338 | 0.050 |
Why?
| | Plant Extracts | 1 | 2025 | 188 | 0.050 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2022 | 41 | 0.050 |
Why?
| | National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2022 | 25 | 0.050 |
Why?
| | Recombination, Genetic | 1 | 2003 | 203 | 0.050 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2022 | 132 | 0.050 |
Why?
| | Aging | 1 | 2013 | 1962 | 0.050 |
Why?
| | Interleukin-12 | 1 | 2022 | 115 | 0.050 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2022 | 161 | 0.040 |
Why?
| | Mothers | 2 | 2018 | 764 | 0.040 |
Why?
| | Immunity | 1 | 2022 | 140 | 0.040 |
Why?
| | Mental Disorders | 1 | 2011 | 1154 | 0.040 |
Why?
| | Codon, Terminator | 1 | 2001 | 25 | 0.040 |
Why?
| | Protein Binding | 2 | 2005 | 2235 | 0.040 |
Why?
| | Twins, Dizygotic | 2 | 2012 | 108 | 0.040 |
Why?
| | Blastocystis hominis | 1 | 2020 | 1 | 0.040 |
Why?
| | Entamoeba | 1 | 2020 | 2 | 0.040 |
Why?
| | Immunologic Factors | 1 | 2022 | 260 | 0.040 |
Why?
| | Systems Biology | 1 | 2021 | 68 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2001 | 387 | 0.040 |
Why?
| | Hypertension, Pulmonary | 1 | 2012 | 1955 | 0.040 |
Why?
| | Cryptosporidium | 1 | 2020 | 15 | 0.040 |
Why?
| | Integrin alpha Chains | 1 | 2020 | 22 | 0.040 |
Why?
| | Methionine-tRNA Ligase | 1 | 2019 | 1 | 0.040 |
Why?
| | Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2020 | 43 | 0.040 |
Why?
| | Giardia lamblia | 1 | 2020 | 23 | 0.040 |
Why?
| | Candida | 1 | 2020 | 45 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2019 | 219 | 0.040 |
Why?
| | Aged | 5 | 2019 | 26096 | 0.040 |
Why?
| | Antibiotic Prophylaxis | 1 | 2020 | 134 | 0.040 |
Why?
| | Spondylarthritis | 1 | 2019 | 50 | 0.040 |
Why?
| | Regression Analysis | 1 | 2021 | 998 | 0.030 |
Why?
| | Microbial Sensitivity Tests | 1 | 2019 | 363 | 0.030 |
Why?
| | Nucleotides | 2 | 2010 | 129 | 0.030 |
Why?
| | Colony Count, Microbial | 1 | 2018 | 89 | 0.030 |
Why?
| | 2-Propanol | 1 | 2017 | 20 | 0.030 |
Why?
| | Databases, Genetic | 2 | 2011 | 238 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 781 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2019 | 1048 | 0.030 |
Why?
| | Administration, Oral | 1 | 2019 | 862 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2018 | 266 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2001 | 2127 | 0.030 |
Why?
| | Toll-Like Receptors | 1 | 2018 | 193 | 0.030 |
Why?
| | Reverse Transcriptase Inhibitors | 1 | 2017 | 87 | 0.030 |
Why?
| | Epigenomics | 1 | 2017 | 112 | 0.030 |
Why?
| | Gene Library | 1 | 2017 | 122 | 0.030 |
Why?
| | HIV Protease Inhibitors | 1 | 2017 | 69 | 0.030 |
Why?
| | Biopsy | 1 | 2020 | 1079 | 0.030 |
Why?
| | Electrocardiography | 1 | 2019 | 664 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 2019 | 820 | 0.030 |
Why?
| | Prospective Studies | 2 | 2018 | 8035 | 0.030 |
Why?
| | Transplant Recipients | 1 | 2017 | 180 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 2026 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2016 | 283 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2018 | 506 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2019 | 2057 | 0.030 |
Why?
| | Allergens | 1 | 2017 | 386 | 0.030 |
Why?
| | Tissue Donors | 1 | 2017 | 419 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2018 | 1131 | 0.030 |
Why?
| | Air Pollution | 1 | 2017 | 312 | 0.020 |
Why?
| | Mucin 5AC | 1 | 2013 | 71 | 0.020 |
Why?
| | Ear, Middle | 1 | 2013 | 84 | 0.020 |
Why?
| | Databases, Factual | 1 | 2019 | 1488 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2021 | 3616 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2018 | 1216 | 0.020 |
Why?
| | Prevalence | 1 | 2020 | 2855 | 0.020 |
Why?
| | Venezuela | 1 | 2012 | 7 | 0.020 |
Why?
| | Mutation | 1 | 2003 | 4071 | 0.020 |
Why?
| | Nucleotide Motifs | 1 | 2012 | 36 | 0.020 |
Why?
| | Malawi | 1 | 2012 | 57 | 0.020 |
Why?
| | Cilia | 1 | 2013 | 173 | 0.020 |
Why?
| | Viral Regulatory and Accessory Proteins | 1 | 2012 | 27 | 0.020 |
Why?
| | San Francisco | 1 | 2012 | 60 | 0.020 |
Why?
| | Phagocytosis | 1 | 2013 | 296 | 0.020 |
Why?
| | Lactobacillus | 1 | 2011 | 28 | 0.020 |
Why?
| | Dogs | 1 | 2013 | 438 | 0.020 |
Why?
| | Models, Statistical | 1 | 2016 | 671 | 0.020 |
Why?
| | Family Characteristics | 1 | 2013 | 195 | 0.020 |
Why?
| | Chronic Disease | 2 | 2008 | 1806 | 0.020 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2017 | 698 | 0.020 |
Why?
| | Programming Languages | 1 | 2011 | 24 | 0.020 |
Why?
| | Formates | 1 | 2011 | 15 | 0.020 |
Why?
| | Probiotics | 1 | 2011 | 61 | 0.020 |
Why?
| | Survival Analysis | 1 | 2013 | 1371 | 0.020 |
Why?
| | Base Pairing | 1 | 2010 | 65 | 0.020 |
Why?
| | United States | 2 | 2022 | 16065 | 0.020 |
Why?
| | South America | 1 | 2010 | 56 | 0.020 |
Why?
| | Information Storage and Retrieval | 1 | 2011 | 123 | 0.020 |
Why?
| | Ecological and Environmental Phenomena | 1 | 2009 | 4 | 0.020 |
Why?
| | Checklist | 1 | 2011 | 110 | 0.020 |
Why?
| | DNA, Fungal | 1 | 2010 | 76 | 0.020 |
Why?
| | DNA | 2 | 2007 | 1433 | 0.020 |
Why?
| | Conserved Sequence | 1 | 2010 | 244 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 2018 | 1993 | 0.020 |
Why?
| | Staphylococcus aureus | 1 | 2013 | 451 | 0.020 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2012 | 627 | 0.020 |
Why?
| | Citrus | 1 | 2009 | 12 | 0.020 |
Why?
| | North America | 1 | 2010 | 301 | 0.020 |
Why?
| | RNA, Transfer | 1 | 2010 | 143 | 0.020 |
Why?
| | Plasmids | 1 | 2010 | 373 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2010 | 531 | 0.020 |
Why?
| | Carnivora | 1 | 2008 | 6 | 0.020 |
Why?
| | Animals, Zoo | 1 | 2008 | 15 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2185 | 0.020 |
Why?
| | Animals, Wild | 1 | 2008 | 60 | 0.020 |
Why?
| | Hand | 1 | 2009 | 157 | 0.020 |
Why?
| | Lentiviruses, Primate | 1 | 2008 | 12 | 0.020 |
Why?
| | Conjugation, Genetic | 1 | 2007 | 5 | 0.020 |
Why?
| | Antibodies, Blocking | 1 | 2007 | 37 | 0.020 |
Why?
| | Insulin | 1 | 2018 | 2510 | 0.020 |
Why?
| | Gene Products, gag | 1 | 2007 | 38 | 0.020 |
Why?
| | Primates | 1 | 2008 | 133 | 0.020 |
Why?
| | Gene Duplication | 1 | 2007 | 66 | 0.020 |
Why?
| | Proteobacteria | 1 | 2007 | 16 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2010 | 1039 | 0.020 |
Why?
| | Models, Molecular | 1 | 2012 | 1597 | 0.020 |
Why?
| | Artificial Intelligence | 1 | 2011 | 381 | 0.020 |
Why?
| | BRCA1 Protein | 1 | 2007 | 82 | 0.020 |
Why?
| | DNA Transposable Elements | 1 | 2007 | 124 | 0.020 |
Why?
| | von Willebrand Factor | 1 | 2007 | 85 | 0.020 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2007 | 174 | 0.010 |
Why?
| | Immunophenotyping | 1 | 2007 | 318 | 0.010 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 919 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2011 | 2115 | 0.010 |
Why?
| | Computer Simulation | 1 | 2010 | 1002 | 0.010 |
Why?
| | Macrophages | 1 | 2013 | 1500 | 0.010 |
Why?
| | Chromatography, Affinity | 1 | 2005 | 80 | 0.010 |
Why?
| | Mice, Obese | 1 | 2005 | 68 | 0.010 |
Why?
| | Bacteriophages | 1 | 2007 | 110 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2018 | 3892 | 0.010 |
Why?
| | Ligands | 1 | 2007 | 664 | 0.010 |
Why?
| | B7-H1 Antigen | 1 | 2007 | 243 | 0.010 |
Why?
| | T-Lymphocyte Subsets | 1 | 2007 | 417 | 0.010 |
Why?
| | Cyanobacteria | 1 | 2005 | 51 | 0.010 |
Why?
| | Lymph Nodes | 1 | 2007 | 502 | 0.010 |
Why?
| | Up-Regulation | 1 | 2007 | 846 | 0.010 |
Why?
| | DNA, Protozoan | 1 | 2003 | 32 | 0.010 |
Why?
| | Interferon-gamma | 1 | 2007 | 784 | 0.010 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2003 | 156 | 0.010 |
Why?
| | Protein Conformation | 1 | 2007 | 936 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2011 | 2136 | 0.010 |
Why?
| | Mosaicism | 1 | 2003 | 73 | 0.010 |
Why?
| | Binding Sites | 1 | 2005 | 1309 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2010 | 3410 | 0.010 |
Why?
| | Haplotypes | 1 | 2003 | 498 | 0.010 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2007 | 917 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2013 | 8318 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2007 | 2504 | 0.010 |
Why?
| | Signal Transduction | 1 | 2007 | 5208 | 0.010 |
Why?
|
|
Lozupone's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|